Sign In
Buy LLY
$1,083.23
+18.39 (+1.73%)
At Close: Jun 03, 2026
QCOM Rally, RCL Regains Bookings Pace, LLY Soars
10:24am, Thursday, 30'th Apr 2026
While Mag 7 names take a lot of the headlines after earnings, the moves from Qualcomm (QCOM), Royal Caribbean (RCL) and Eli Lilly (LLY) are on Diane King Hall's radar following Thursday's open. She br
US FDA proposes excluding weight-loss drugs from compounding list
09:54am, Thursday, 30'th Apr 2026
The U.S. Food and Drug Administration on Thursday proposed excluding active ingredients for Novo Nordisk and Eli Lilly's weight-loss drugs on the list of drugs outsourcing facilities can use
S&P 500 Rides Tech Earnings Wave Despite Inflation Warning Shot
09:09am, Thursday, 30'th Apr 2026
The S&P 500 (^GSPC) is off to the races this morning, up 0.50% thanks to tailwinds from mega-cap earnings beats and a sharp pullback in oil prices, even as the Fed's preferred inflation gauge ran hott
Eli Lilly (LLY) Beats Q1 Earnings and Revenue Estimates
08:55am, Thursday, 30'th Apr 2026
Eli Lilly (LLY) came out with quarterly earnings of $8.55 per share, beating the Zacks Consensus Estimate of $7.06 per share. This compares to earnings of $3.34 per share a year ago.
Consumer demand for blockbusters Mounjaro and Zepbound helped offset declining prices for the drugs.
Eli Lilly stock jumps 6% after strong earnings and raised guidance
07:19am, Thursday, 30'th Apr 2026
Eli Lilly reported stronger-than-expected first-quarter earnings and revenue on Thursday, driven by robust demand for its blockbuster weight-loss and diabetes drugs, prompting the company to raise its
Eli Lilly Stock Jumps on Earnings Beat as Zepbound and Mounjaro Sales Skyrocket
07:08am, Thursday, 30'th Apr 2026
Revenue tied to Lilly's Zepbound and Mounjaro more than doubles from the same period last year.
Lilly reports first-quarter 2026 financial results, raises full year guidance, and highlights momentum of new medicines
06:45am, Thursday, 30'th Apr 2026
Revenue in Q1 2026 increased 56% to $19.8 billion primarily driven by volume growth, partially offset by lower realized prices from Mounjaro and Zepbound. Q1 2026 EPS increased by 170% to $8.26 on a r
Eli Lilly Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
02:47am, Thursday, 30'th Apr 2026
Eli Lilly and Company (NYSE:LLY) will release earnings for its first quarter before the opening bell on Thursday, April 30.
Eli Lilly Stock Could Rise Sharply After Earnings
02:00pm, Wednesday, 29'th Apr 2026
Eli Lilly and Company has declined over 20% since January despite strong anticipated Q1 results and has not participated in the recent market rally. Options market positioning is extremely bearish wit
Here's How Much Traders Expect Eli Lilly Stock To Move After Earnings
01:47pm, Wednesday, 29'th Apr 2026
Eli Lilly is scheduled to report its latest quarterly earnings ahead of the opening bell Thursday, with shares seen potentially falling to their lowest level in months following the report.
Artisan Global Opportunities Fund Q1 2026 Portfolio Activity
11:13am, Wednesday, 29'th Apr 2026
During the quarter, we initiated new positions in Edwards Lifesciences, Eli Lilly and Roblox. In addition to Linde, Shopify and Amazon, we also added to Woodward and Spotify during the quarter. We end
Eli Lilly investors are eager for Foundayo insight after early launch data
06:02am, Wednesday, 29'th Apr 2026
Eli Lilly investors will be searching for something they won't find in any first-quarter financial figures reported on Thursday: insight into the launch of weight-loss pill Foundayo.
Is Eli Lilly Stock Undervalued at $870? 1 Top Wall Street Analyst Thinks So
06:15pm, Tuesday, 28'th Apr 2026
One analyst thinks Eli Lilly's shares boast significant upside potential. The company's weight loss portfolio could help drive solid growth over the medium term.
Pharmaceutical Stock Pulling Back Before Earnings
02:44pm, Tuesday, 28'th Apr 2026
Eli Lilly And Co (NYSE:LLY) stock is down 0.3% to trade at $865.41 at last glance, pulling back alongside the broader market.
